您的位置: 专家智库 > >

国家自然科学基金(81273617)

作品数:8 被引量:28H指数:3
相关作者:杨钦河梁荫基龚享文张玉佩刘益臻更多>>
相关机构:暨南大学汕头市澄海区人民医院暨南大学附属第一医院更多>>
发文基金:国家自然科学基金中国博士后科学基金广东省科技计划工业攻关项目更多>>
相关领域:医药卫生更多>>

文献类型

  • 8篇中文期刊文章

领域

  • 8篇医药卫生

主题

  • 3篇脂肪
  • 3篇中医
  • 3篇中医药
  • 2篇医药防治
  • 2篇脂肪性
  • 2篇脂肪性肝病
  • 2篇脾虚
  • 2篇中医药防治
  • 2篇酒精
  • 2篇酒精性
  • 2篇酒精性脂肪性...
  • 2篇非酒精性
  • 2篇非酒精性脂肪
  • 2篇非酒精性脂肪...
  • 2篇非酒精性脂肪...
  • 2篇非酒精性脂肪...
  • 2篇肝病
  • 2篇NAFLD
  • 1篇代谢
  • 1篇代谢紊乱

机构

  • 6篇暨南大学
  • 1篇暨南大学附属...
  • 1篇汕头市澄海区...

作者

  • 5篇梁荫基
  • 5篇杨钦河
  • 4篇闫海震
  • 4篇龚享文
  • 4篇刘益臻
  • 4篇张玉佩
  • 2篇张金文
  • 2篇林春梅
  • 2篇徐拥建
  • 2篇王观龙
  • 2篇李媛媛
  • 1篇黄进
  • 1篇金玲
  • 1篇韩莉
  • 1篇王少娜

传媒

  • 1篇中国实验方剂...
  • 1篇医学信息(医...
  • 1篇中国中西医结...
  • 1篇广东医学
  • 1篇成都中医药大...
  • 1篇Journa...
  • 1篇亚太传统医药
  • 1篇Chines...

年份

  • 1篇2018
  • 1篇2016
  • 1篇2015
  • 4篇2014
  • 1篇2013
8 条 记 录,以下是 1-8
排序方式:
中医药防治非酒精性脂肪性肝病抗氧化作用研究进展
2014年
以中药复方、中药提取物和单体、中医非药物疗法为主要研究对象,对近年来中医药从抗氧化角度防治非酒精性脂肪性肝病的研究进展做一综述,并对现阶段研究水平进行评价,同时提出进一步研究的靶点。
刘益臻杨钦河张玉佩梁荫基
关键词:中医药非酒精性脂肪性肝病抗氧化作用
Effects of Berberine on Hepatic Sirtuin 1-uncoupling Protein 2 Pathway in Non-alcoholic Fatty Liver Disease Rats Induced by High-fat Diet被引量:2
2016年
Objective To investigate the involvement of sirtuin 1(SIRT1)-uncoupling protein 2(UCP2) pathway in the development of non-alcoholic fatty liver disease and whether berberine exerts its effects by regulating this pathway. Methods Male SD rats were divided into three groups: normal control group, high-fat diet group, and berberine supplement group. The rats in the normal control group were given normal diet while the rats in the other two groups were fed with high-fat diet. Rats in the berberine supplement group were concurrently given berberine(100 mg/kg body weight) once daily. After 16 weeks, the levels of serum, liver lipids, and serum aminotransferase were measured using an automatic biochemical analyzer. Superoxide dismutase(SOD) activity and malondialdehyde(MDA) content in the liver were measured using commercial kits. Histopathological changes of liver tissues were observed by hematoxylin and eosin(HE) staining and Oil Red O staining. The hepatic m RNA and protein levels of SIRT1 and UCP2 were assayed by reverse transcription polymerase chain reaction(RT-PCR) or Western blotting. Results Berberine supplement could significantly decrease the serum and liver lipid contents in rats fed with high-fat diet. Meanwhile, SOD level was significantly elevated, but MDA level was reduced in the liver. The results of HE and Oil Red O staining showed that the hepatic steatosis was alleviated in berberine supplement group. Furthermore, berberine induced an increase in SIRT1 expression but a decrease in UCP2 expression. Conclusion The regulation of hepatic SIRT1-UCP2 pathway may be an important mechanism by which berberine exerts the beneficial effects in NAFLD rats.
Yuan-jun DengYu-pei ZhangQin-he YangLi HanYin-ji LiangYi-fang HeYuan-yuan LiGuan-long WangChun-mei LinJin-wen Zhang
Effects of extracts from soothing-liver and invigorating-spleen formulas on the injury induced by oxidative stress in the hepatocytes of rats with non-alcoholic fatty liver disease induced by high-fat diet被引量:2
2018年
OBJECTIVE:To investigate effects of the extracts from soothing-liver and invigorating-spleen formulas on the injury due to oxidative stress,mediated by the Nuclear factor-like 2(Nrf2)-Antioxidant response element(ARE) pathway,in the hepatocytes of rats with non-alcoholic fatty liver disease(NAFLD) induced by high-fat diet.METHODS:Soothing-liver and invigorating-spleen formula mixtures were prepared for five groups:normal,model,soothing-liver formula group(SLG),invigorating-spleen formula group(ISG),integrated formula group(IG).The rat model of NAFLD was induced by feeding rats a high-fat diet(HFD).After 16 weeks,the hepatic tissue was examined following Haematoxylin-Eosin(H&E) staining and with Transmission electron microscopy(TEM).Levels of hepatic lipids,serum lipids and hepatic functions were measured using a biochemical analyser.Hepatocytes were isolated from the livers of rats and were identified by cellar immunohistochemistry,cellular immunofluorescence and flow cytometry.The expression levels of Nrf2,Kelch-like epichlorohydrin-associated protein 1(Keap-1),haeme oxygenase-1(HO-1) and NAD(P)H:quinone oxidoreductase 1(NQO1) m RNAs were assessed by real-time fluorescence quantitative PCR.Nrf2,Keap-1,HO-1 and NQO1 proteins were measured by Western blotting.Finally,the levels of oxidative stress factors Superoxide Dismutase(SOD),malonaldehyde(MDA) and Glutathione peroxidase(GSH-Px) in hepatocytes were measured by WST-1,TBA and colorimetry.RESULTS:The H & E and TEM results showed that the NAFLD model rats successfully reproduced typical pathogenetic and histopathological features.The liver function and levels of hepatic lipids and serum lipids from the model rats were dramatically increased.Compared with the model group,the levels of hepatic lipids,serum lipids and hepatic function in the treatment groups were ameliorated to different degrees.The yields of purified hepatocytes in each rat were 4-5 × 108.The viability of the isolated hepatocytes was higher than 95%,with a purity over 93.2%.Cellular immunohistoche
Tu GuifangGong XiangwenYang QinheLi YuanyuanWang GuanlongLiang YinjiZhang YupeiYan HaizhenLin ChunmeiZhang Jinwen
将转化医学引入NAFLD的中医药防治研究被引量:1
2014年
该文介绍了转化医学(Translational Medicine)的概念,产生的时代背景及在中国的应用和发展,并结合转化医学的理念,分别从非酒精性脂肪性肝病(Non-alcoholic Fatty Liver Disease,NAFLD)的临床研究、基础研究、名老中医思想传承、转化医学平台和团队建设等方面,论述了转化医学理念在中医药防治非酒精性脂肪性肝病中的应用,以期与同道交流,为中医临床研究提供借鉴和参考。
张金文杨钦河龚享文张玉佩林春梅梁荫基刘益臻王观龙李媛媛闫海震
关键词:NAFLD中医学疗效评价
NLRP6在非酒精性脂肪性肝病发病中的作用及中医药防治策略被引量:6
2014年
非酒精性脂肪性肝病(nonalcoholic fatty liver disease,NAFLD)全球发病形势严峻,临床对其防治仍然缺乏有效手段。目前,NAFLD的发病机制尚未完全清楚,普遍认为与胰岛素抵抗(insulin resistance)、脂质代谢紊乱、氧化应激、脂质过氧化、炎症细胞因子等因素密切相关[1]。从中医病机看,肝脾两脏关系密切,肝脾同病在慢性肝病中极为常见。现代研究表明NAFLD的发生发展与肝脾两脏的功能失调有关,肝郁脾虚是NAFLD发病的基本病机[2]。
梁荫基杨钦河张玉佩王少娜韩莉刘益臻金玲龚享文闫海震徐拥建
关键词:非酒精性脂肪性肝病中医药防治NAFLD脂质代谢紊乱炎症细胞因子LIVER
参苓白术散的实验研究进展
2014年
本文通过综述参苓白术散对非酒精性脂肪性肝病、免疫功能的调节、中医脾虚证的干预、肠胃动力及肠道菌群的影响,表明参苓白术散能调节相关mRNA及功能性蛋白的表达,从而防治NAFLD的发生与发展;调节相关免疫细胞功能,改善机体免疫机能;增加或减少相应肠道细菌的数量,恢复肠道菌群平衡,保护肠道粘膜组织;双向改善胃肠动力,治疗胃动力不足或腹泻,为相关中医药的研究提供指导和参考。
税嘉诚胡财愿刘奕均金幸王诗白孙建鑫付航廖国澳梁荫基闫海震杨钦河
关键词:参苓白术散
Nrf2/ARE通路在肝脏疾病中的研究进展被引量:6
2015年
氧化应激是指机体在遭受各种有害刺激时,体内高活性分子如活性氧自由基(reactive oxygen species,ROS)和活性氮自由基(reactive nitro genspecies,RNS)产生过多,氧化程度超出氧化物的清除,氧化系统和抗氧化系统失衡,从而导致组织损伤。氧化应激可造成多种细胞成分(包括DNA、蛋白质和脂质)损害,累及人体各器官及系统。
林春梅梁荫基张金文刘益臻张玉佩闫海震徐拥健龚享文李媛媛王观龙杨钦河
关键词:氧化应激肝脏疾病
基于数据挖掘脂肪肝肝郁脾虚证用药规律研究被引量:11
2013年
目的:基于数据挖掘方法探索脂肪肝肝郁脾虚证用药规律。方法:利用VIP、CBM和CNKI等数据库检索创建以来至2012年9月关于中治疗脂肪肝肝郁脾虚证的文献,同时手工检索2002~2012年出版的有关脂肪肝肝郁脾虚证论述的书目。将符合要求的文献和书目建立数据库,由研究人员对文献进行筛选和数据提取,进行频数分析、聚类分析,关联规则分析。对主要药物、药对(组)规律进行研究。结果:在治疗脂肪肝肝郁脾虚证的104首中药复方中,涉及163种药物,使用频次为1 227次;其中使用频次在4次以上的共46种、共855频次;作为主要药物进行聚类分析,共分为6类:疏肝类、健脾类、化痰类、行气类、化瘀类、消食类;经关联规则分析,共得药对规则14条,药组规则62条,主要为疏肝理气药与健脾祛湿药的配伍组合。结论:数据挖掘能够更好的探索治疗脂肪肝肝郁脾虚证用药规律,更好的指导临床和中药开发。
龚享文杨钦河徐拥建黄进
关键词:数据挖掘脂肪肝肝郁脾虚用药规律
共1页<1>
聚类工具0